Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fruehauf

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|January 11, 2011
Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimensE Jantunen, S Fruehauf
Cytotherapy|August 6, 2005
New developments in stem cell biology and therapy. First meeting report from the working group of the German Society for Hematology and OncologyS Fruehauf, A D Ho
Transplantation Proceedings|September 25, 2002
Transplantation of human hematopoietic progenitor cells transduced with a retroviral vector containing the human multidrug-resistance-1 gene for myeloprotective gene therapyS Laufs, C Baum, S Fruehauf
Cytotherapy|October 21, 2005
Innovative strategies for PBPC mobilizationS Fruehauf, T Seeger, J Topaly
British Journal of Haematology|October 3, 2002
Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studiesJ Topaly, W J Zeller, S Fruehauf
Leukemia|March 10, 2001
Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cellsJ Topaly, W J Zeller, S Fruehauf
Annals of Hematology|July 12, 2001
Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemiaS Fruehauf, S Steiger, J Topaly, et al.
Journal of Hematotherapy|August 1, 1996
Human-mouse xenografts in stem cell researchK Wermann, S Fruehauf, R Haas, et al.
Journal of Hematotherapy|August 1, 1996
Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hoursS Murea, S Fruehauf, W J Zeller, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursorsS Fruehauf, R Haas, W J Zeller, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|January 11, 2011
Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimensE Jantunen, S Fruehauf
Cytotherapy|August 6, 2005
New developments in stem cell biology and therapy. First meeting report from the working group of the German Society for Hematology and OncologyS Fruehauf, A D Ho
Transplantation Proceedings|September 25, 2002
Transplantation of human hematopoietic progenitor cells transduced with a retroviral vector containing the human multidrug-resistance-1 gene for myeloprotective gene therapyS Laufs, C Baum, S Fruehauf
Cytotherapy|October 21, 2005
Innovative strategies for PBPC mobilizationS Fruehauf, T Seeger, J Topaly
British Journal of Haematology|October 3, 2002
Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studiesJ Topaly, W J Zeller, S Fruehauf
Leukemia|March 10, 2001
Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cellsJ Topaly, W J Zeller, S Fruehauf
Annals of Hematology|July 12, 2001
Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemiaS Fruehauf, S Steiger, J Topaly, et al.
Journal of Hematotherapy|August 1, 1996
Human-mouse xenografts in stem cell researchK Wermann, S Fruehauf, R Haas, et al.
Journal of Hematotherapy|August 1, 1996
Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hoursS Murea, S Fruehauf, W J Zeller, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursorsS Fruehauf, R Haas, W J Zeller, et al.
Pageof 6